Advances in Cancer Research (2023)
The clinical role of glycobiology on ovarian cancer progression
Authors: Rhyisa Armbrister, Laura Ochoa, Karen L. Abbott
DOI: 10.1016/bs.acr.2022.07.004PMID: 36725106
Overview & Significance
Discusses the role of glycans and glycoproteins in ovarian cancer progression and the potential diagnostic and therapeutic significance of cancer-associated glycan changes.
Glycobiology plays a crucial clinical role in understanding ovarian cancer progression. Alterations in protein glycosylation significantly impact tumor cell adhesion, migration, immune evasion, and drug resistance. This work explores cancer-associated glycan structures as potential biomarkers and therapeutic targets in epithelial ovarian cancer.
Key Research Concepts
Ovarian Cancer GlycobiologyProtein GlycosylationCancer BiomarkersTargeted TherapeuticsTumor Microenvironment